Detalles de la búsqueda
1.
[The importance of health-related quality of life at baseline in predicting event-free survival in patients with a cardiovascular risk profile]. / Die Bedeutung gesundheitsbezogener Lebensqualität für die Vorhersage des ereignisfreien Überlebens bei Patienten mit kardiovaskulärem Risikoprofil.
Z Psychosom Med Psychother;
67(4): 361-380, 2021 Dec.
Artículo
en Alemán
| MEDLINE | ID: mdl-34904553
2.
Coping styles as predictors for quality of life and prognosis in patients at risk for or with a diagnosis of heart failure: Results from the observational DIAST-CHF study.
J Psychosom Res;
170: 111384, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244069
3.
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.
ESC Heart Fail;
10(1): 200-210, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36184749
4.
Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update.
Expert Opin Pharmacother;
23(6): 673-680, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260016
5.
Evaluation of the HFA-PEFF Score: results from the prospective DIAST-CHF cohort.
ESC Heart Fail;
9(6): 4120-4128, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36070881
6.
NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
ESC Heart Fail;
9(1): 100-109, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850596
7.
Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction.
ESC Heart Fail;
8(6): 4635-4643, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480783
8.
The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study.
ESC Heart Fail;
8(2): 829-841, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33566456
9.
Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction.
Int J Cardiol Heart Vasc;
28: 100525, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420447
10.
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
ESC Heart Fail;
6(2): 262-270, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30784226
11.
Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.
ESC Heart Fail;
5(1): 53-62, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29210202
12.
Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study.
J Am Soc Hypertens;
11(5): 303-313, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411073
13.
Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study.
ESC Heart Fail;
4(1): 56-65, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28217313
14.
Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.
Eur J Heart Fail;
19(8): 1067-1074, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28516519
15.
Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study.
PLoS One;
10(8): e0136739, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26322793
16.
[GDF-15, MRproADM, CTproET1, and CTproAVP in patients with asymptomatic diastolic dysfunction]. / GDF-15, MRproADM, CTproET1 und CTproAVP bei Patienten mit asymptomatischer diastolischer Dysfunktion.
Dtsch Med Wochenschr;
140(13): e120-8, 2015 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-26115140
17.
Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.
Clin Res Cardiol;
104(7): 574-81, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25665711
18.
Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.
ESC Heart Fail;
2(2): 76-84, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28834659
19.
Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.
Eur J Prev Cardiol;
22(5): 582-93, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24627449
20.
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
Eur J Heart Fail;
17(2): 214-23, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25418979